ID   F13B_HUMAN              Reviewed;         661 AA.
AC   P05160; A8K3E5; Q5VYL5;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 3.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Coagulation factor XIII B chain;
DE   AltName: Full=Fibrin-stabilizing factor B subunit;
DE   AltName: Full=Protein-glutamine gamma-glutamyltransferase B chain;
DE   AltName: Full=Transglutaminase B chain;
DE   Flags: Precursor;
GN   Name=F13B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-115.
RX   PubMed=2271707; DOI=10.1021/bi00503a007;
RA   Bottenus R.E., Ichinose A., Davie E.W.;
RT   "Nucleotide sequence of the gene for the b subunit of human factor
RT   XIII.";
RL   Biochemistry 29:11195-11209(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-661, PROTEIN SEQUENCE OF N-TERMINUS,
RP   AND VARIANT HIS-115.
RX   PubMed=3021194; DOI=10.1021/bi00364a027;
RA   Ichinose A., McMullen B.A., Fujikawa K., Davie E.W.;
RT   "Amino acid sequence of the b subunit of human factor XIII, a protein
RT   composed of ten repetitive segments.";
RL   Biochemistry 25:4633-4638(1986).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ichinose A.;
RL   Submitted (FEB-1987) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-569.
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-115; THR-342;
RP   ARG-350; PRO-529 AND GLU-569.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-20.
RC   TISSUE=Liver;
RX   PubMed=2339067; DOI=10.1093/nar/18.9.2817;
RA   Grundmann U., Nerlich C., Rein T., Zettlmeissl G.;
RT   "Complete cDNA sequence encoding the B subunit of human factor XIII.";
RL   Nucleic Acids Res. 18:2817-2817(1990).
RN   [8]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=4405643;
RA   Schwartz M.L., Pizzo S.V., Hill R.L., McKee P.A.;
RT   "Human Factor XIII from plasma and platelets. Molecular weights,
RT   subunit structures, proteolytic activation, and cross-linking of
RT   fibrinogen and fibrin.";
RL   J. Biol. Chem. 248:1395-1407(1973).
RN   [9]
RP   INVOLVEMENT IN FA13BD.
RX   PubMed=11313256; DOI=10.1182/blood.V97.9.2667;
RA   Koseki S., Souri M., Koga S., Yamakawa M., Shichishima T.,
RA   Maruyama Y., Yanai F., Ichinose A.;
RT   "Truncated mutant B subunit for factor XIII causes its deficiency due
RT   to impaired intracellular transportation.";
RL   Blood 97:2667-2672(2001).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-545.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-162.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   REVIEW.
RX   PubMed=21742792; DOI=10.1152/physrev.00016.2010;
RA   Muszbek L., Bereczky Z., Bagoly Z., Komaromi I., Katona E.;
RT   "Factor XIII: a coagulation factor with multiple plasmatic and
RT   cellular functions.";
RL   Physiol. Rev. 91:931-972(2011).
RN   [13]
RP   VARIANT FA13BD PHE-450.
RX   PubMed=8324218;
RA   Hashiguchi T., Saito M., Morishita E., Matsuda T., Ichinose A.;
RT   "Two genetic defects in a patient with complete deficiency of the b-
RT   subunit for coagulation factor XIII.";
RL   Blood 82:145-150(1993).
RN   [14]
RP   VARIANTS VAL-49; HIS-115; ARG-350; VAL-388; SER-543 AND GLU-569.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [15]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [16]
RP   VARIANTS FA13BD ARG-25; ASN-101; PHE-136; ILE-237; PHE-336; GLU-421
RP   AND SER-448.
RX   PubMed=20331752; DOI=10.1111/j.1365-2516.2010.02207.x;
RA   Ivaskevicius V., Biswas A., Loreth R., Schroeder V., Ohlenforst S.,
RA   Rott H., Krause M., Kohler H.P., Scharrer I., Oldenburg J.;
RT   "Mutations affecting disulphide bonds contribute to a fairly common
RT   prevalence of F13B gene defects: results of a genetic study in 14
RT   families with factor XIII B deficiency.";
RL   Haemophilia 16:675-682(2010).
RN   [17]
RP   CHARACTERIZATION OF VARIANTS FA13BD ARG-25; ASN-101; PHE-136; ILE-237;
RP   PHE-336; GLU-421 AND SER-448, SUBCELLULAR LOCATION, SUBUNIT, AND
RP   INTERACTION WITH F13A1.
RX   PubMed=26247044; DOI=10.1002/mgg3.138;
RA   Thomas A., Biswas A., Ivaskevicius V., Oldenburg J.;
RT   "Structural and functional influences of coagulation factor XIII
RT   subunit B heterozygous missense mutants.";
RL   Mol. Genet. Genomic Med. 3:258-271(2015).
CC   -!- FUNCTION: The B chain of factor XIII is not catalytically active,
CC       but is thought to stabilize the A subunits and regulate the rate
CC       of transglutaminase formation by thrombin.
CC       {ECO:0000303|PubMed:21742792, ECO:0000303|PubMed:3021194}.
CC   -!- SUBUNIT: Tetramer of two A chains (F13A1) and two B (F13B) chains.
CC       {ECO:0000269|PubMed:26247044, ECO:0000269|PubMed:4405643}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:26247044,
CC       ECO:0000269|PubMed:4405643}.
CC   -!- DISEASE: Factor XIII subunit B deficiency (FA13BD) [MIM:613235]:
CC       An autosomal recessive hematologic disorder characterized by a
CC       life-long bleeding tendency, impaired wound healing and
CC       spontaneous abortion in affected women.
CC       {ECO:0000269|PubMed:11313256, ECO:0000269|PubMed:20331752,
CC       ECO:0000269|PubMed:26247044, ECO:0000269|PubMed:8324218}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=F&genename=F13B+%40+FXIIIB";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Factor XIII entry;
CC       URL="https://en.wikipedia.org/wiki/Factor_XIII";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/f13b/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64554; AAA51821.1; -; Genomic_DNA.
DR   EMBL; M14057; AAA88042.1; -; mRNA.
DR   EMBL; AK290560; BAF83249.1; -; mRNA.
DR   EMBL; AY692223; AAT85802.1; -; Genomic_DNA.
DR   EMBL; AL353809; CAH72549.1; -; Genomic_DNA.
DR   EMBL; X51823; CAA36123.1; -; mRNA.
DR   CCDS; CCDS1388.1; -.
DR   PIR; A36397; KFHU13.
DR   RefSeq; NP_001985.2; NM_001994.2.
DR   UniGene; Hs.435782; -.
DR   ProteinModelPortal; P05160; -.
DR   SMR; P05160; -.
DR   BioGrid; 108463; 2.
DR   STRING; 9606.ENSP00000356382; -.
DR   ChEMBL; CHEMBL3351193; -.
DR   iPTMnet; P05160; -.
DR   PhosphoSitePlus; P05160; -.
DR   BioMuta; F13B; -.
DR   DMDM; 145559473; -.
DR   EPD; P05160; -.
DR   PaxDb; P05160; -.
DR   PeptideAtlas; P05160; -.
DR   PRIDE; P05160; -.
DR   DNASU; 2165; -.
DR   Ensembl; ENST00000367412; ENSP00000356382; ENSG00000143278.
DR   GeneID; 2165; -.
DR   KEGG; hsa:2165; -.
DR   UCSC; uc001gtt.1; human.
DR   CTD; 2165; -.
DR   DisGeNET; 2165; -.
DR   GeneCards; F13B; -.
DR   H-InvDB; HIX0028859; -.
DR   HGNC; HGNC:3534; F13B.
DR   HPA; HPA003827; -.
DR   HPA; HPA052139; -.
DR   MalaCards; F13B; -.
DR   MIM; 134580; gene+phenotype.
DR   MIM; 613235; phenotype.
DR   neXtProt; NX_P05160; -.
DR   OpenTargets; ENSG00000143278; -.
DR   Orphanet; 331; Congenital factor XIII deficiency.
DR   PharmGKB; PA27944; -.
DR   eggNOG; ENOG410IE82; Eukaryota.
DR   eggNOG; ENOG410YE48; LUCA.
DR   GeneTree; ENSGT00870000136398; -.
DR   HOGENOM; HOG000049250; -.
DR   HOVERGEN; HBG005626; -.
DR   InParanoid; P05160; -.
DR   KO; K03906; -.
DR   OMA; PLCTRKE; -.
DR   OrthoDB; EOG091G03MW; -.
DR   PhylomeDB; P05160; -.
DR   TreeFam; TF326157; -.
DR   Reactome; R-HSA-140875; Common Pathway of Fibrin Clot Formation.
DR   GeneWiki; F13B; -.
DR   GenomeRNAi; 2165; -.
DR   PRO; PR:P05160; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143278; -.
DR   CleanEx; HS_F13B; -.
DR   Genevisible; P05160; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   CDD; cd00033; CCP; 7.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   Pfam; PF00084; Sushi; 8.
DR   SMART; SM00032; CCP; 8.
DR   SUPFAM; SSF57535; SSF57535; 10.
DR   PROSITE; PS50923; SUSHI; 7.
PE   1: Evidence at protein level;
KW   Blood coagulation; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Glycoprotein; Hemostasis;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal; Sushi.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:3021194}.
FT   CHAIN        21    661       Coagulation factor XIII B chain.
FT                                /FTId=PRO_0000021222.
FT   DOMAIN       24     88       Sushi 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN       89    148       Sushi 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      151    210       Sushi 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      211    269       Sushi 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      272    329       Sushi 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      334    391       Sushi 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      394    452       Sushi 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      453    516       Sushi 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      522    580       Sushi 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      581    647       Sushi 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   MOTIF       617    619       Cell attachment site.
FT   CARBOHYD    162    162       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    545    545       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   DISULFID     25     76       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID     59     87       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID     91    135       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    118    146       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    153    197       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    180    208       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    213    255       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    241    267       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    274    316       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    302    327       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    336    378       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    364    389       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    396    439       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    425    450       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    454    505       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    486    515       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    524    567       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    553    578       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    582    636       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    616    646       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   VARIANT      25     25       C -> R (in FA13BD; may disrupt a
FT                                disulfide bond; impaired subcellular
FT                                location leading to accumulation in the
FT                                endoplasmic reticulum; impaired
FT                                interaction with F13A1; impaired
FT                                structure). {ECO:0000269|PubMed:20331752,
FT                                ECO:0000269|PubMed:26247044}.
FT                                /FTId=VAR_074563.
FT   VARIANT      49     49       M -> V (in dbSNP:rs6002).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_013930.
FT   VARIANT     101    101       I -> N (in FA13BD; impaired interaction
FT                                with F13A1; dbSNP:rs753009140).
FT                                {ECO:0000269|PubMed:20331752,
FT                                ECO:0000269|PubMed:26247044}.
FT                                /FTId=VAR_074564.
FT   VARIANT     115    115       R -> H (in dbSNP:rs6003).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:2271707,
FT                                ECO:0000269|PubMed:3021194,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_013931.
FT   VARIANT     136    136       L -> F (in FA13BD; unknown pathological
FT                                significance; dbSNP:rs757094432).
FT                                {ECO:0000269|PubMed:20331752,
FT                                ECO:0000269|PubMed:26247044}.
FT                                /FTId=VAR_074565.
FT   VARIANT     237    237       V -> I (in FA13BD; unknown pathological
FT                                significance; dbSNP:rs145637157).
FT                                {ECO:0000269|PubMed:20331752,
FT                                ECO:0000269|PubMed:26247044}.
FT                                /FTId=VAR_074566.
FT   VARIANT     336    336       C -> F (in FA13BD; may disrupt a
FT                                disulfide bond; impaired interaction with
FT                                F13A1; impaired structure;
FT                                dbSNP:rs778826479).
FT                                {ECO:0000269|PubMed:20331752,
FT                                ECO:0000269|PubMed:26247044}.
FT                                /FTId=VAR_074567.
FT   VARIANT     342    342       I -> T (in dbSNP:rs17514281).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_020612.
FT   VARIANT     350    350       H -> R (in dbSNP:rs5999).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_013932.
FT   VARIANT     388    388       E -> V (in dbSNP:rs5991).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_013933.
FT   VARIANT     421    421       V -> E (in FA13BD; impaired interaction
FT                                with F13A1).
FT                                {ECO:0000269|PubMed:20331752,
FT                                ECO:0000269|PubMed:26247044}.
FT                                /FTId=VAR_074568.
FT   VARIANT     448    448       P -> S (in FA13BD; impaired interaction
FT                                with F13A1; impaired structure).
FT                                {ECO:0000269|PubMed:20331752,
FT                                ECO:0000269|PubMed:26247044}.
FT                                /FTId=VAR_074569.
FT   VARIANT     450    450       C -> F (in FA13BD; dbSNP:rs121913075).
FT                                {ECO:0000269|PubMed:8324218}.
FT                                /FTId=VAR_007475.
FT   VARIANT     529    529       L -> P (in dbSNP:rs17549671).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_020613.
FT   VARIANT     543    543       Y -> S (in dbSNP:rs6001).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_013934.
FT   VARIANT     569    569       D -> E (in dbSNP:rs6000).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_013935.
SQ   SEQUENCE   661 AA;  75511 MW;  57A2FD2A0E35B812 CRC64;
     MRLKNLTFII ILIISGELYA EEKPCGFPHV ENGRIAQYYY TFKSFYFPMS IDKKLSFFCL
     AGYTTESGRQ EEQTTCTTEG WSPEPRCFKK CTKPDLSNGY ISDVKLLYKI QENMRYGCAS
     GYKTTGGKDE EVVQCLSDGW SSQPTCRKEH ETCLAPELYN GNYSTTQKTF KVKDKVQYEC
     ATGYYTAGGK KTEEVECLTY GWSLTPKCTK LKCSSLRLIE NGYFHPVKQT YEEGDVVQFF
     CHENYYLSGS DLIQCYNFGW YPESPVCEGR RNRCPPPPLP INSKIQTHST TYRHGEIVHI
     ECELNFEIHG SAEIRCEDGK WTEPPKCIEG QEKVACEEPP FIENGAANLH SKIYYNGDKV
     TYACKSGYLL HGSNEITCNR GKWTLPPECV ENNENCKHPP VVMNGAVADG ILASYATGSS
     VEYRCNEYYL LRGSKISRCE QGKWSSPPVC LEPCTVNVDY MNRNNIEMKW KYEGKVLHGD
     LIDFVCKQGY DLSPLTPLSE LSVQCNRGEV KYPLCTRKES KGMCTSPPLI KHGVIISSTV
     DTYENGSSVE YRCFDHHFLE GSREAYCLDG MWTTPPLCLE PCTLSFTEME KNNLLLKWDF
     DNRPHILHGE YIEFICRGDT YPAELYITGS ILRMQCDRGQ LKYPRCIPRQ STLSYQEPLR
     T
//
